Publication | Closed Access

Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors

ThrombosisBreast OncologyVenous ThrombosisMedicinePharmacologyBreast Cancer SurvivorsGynecologyBreast CancerPharmacotherapyAromataseTamoxifen UseAromatase InhibitorOncologyRadiation OncologyEndocrine-related CancerWomen's Health